Antios Therapeutics
OverviewSuggest Edit
Antios Therapeutics is a biopharmaceutical company devoted to developing innovative therapies for viral diseases. The Company is focused on the development of its lead oral drug candidate for a potentially curative treatment of HBV infections.
| Type | Private | |
| Founded | 2018 | |
| HQ | Atlanta, GA, US | Map |
| Website | antiostherapeutics.com |
Recent NewsAll News
- Antios Therapeutics Appoints Accomplished Financial Executive, Tamra J. Adams, as its first Chief Financial Officer
- Antios Therapeutics Appoints Patrick T. Higgins to Board of Directors
- Antios Therapeutics Completes Phase 1b Clinical Trial of ATI-2173, an Active Site Polymerase Inhibitor Nucleotide (ASPIN), in Patients with Chronic Hepatitis B Virus Infection
- Antios Therapeutics Appoints Gregory T. Mayes Chief Executive Officer
Latest Updates
| Employees (est.) (Mar 2021) | 13 | (+19%) |
| Cybersecurity rating | A | More |
Antios Therapeutics Office Locations
Antios Therapeutics Financials and Metrics
Summary Metrics
Founding Date | 2018 |
Antios Therapeutics total Funding | $25 m |
Antios Therapeutics latest funding size | $25 m |
Time since last funding | 2 years ago |
Antios Therapeutics investors | Fonds de solidarité FTQ, Domain Associates, Georgia Research Alliance, CAM Capital, Lumira Ventures |
Antios Therapeutics Cybersecurity Score
Antios Therapeutics Online and Social Media Presence
Antios Therapeutics's Trends
Antios Therapeutics News and Updates
Antios Therapeutics Appoints Accomplished Financial Executive, Tamra J. Adams, as its first Chief Financial Officer
Antios Therapeutics Appoints Patrick T. Higgins to Board of Directors
Antios Therapeutics Completes Phase 1b Clinical Trial of ATI-2173, an Active Site Polymerase Inhibitor Nucleotide (ASPIN), in Patients with Chronic Hepatitis B Virus Infection
Antios Therapeutics Appoints Gregory T. Mayes Chief Executive Officer
Antios Therapeutics Frequently Asked Questions
When was Antios Therapeutics founded?
Antios Therapeutics was founded in 2018.
How many employees does Antios Therapeutics have?
Antios Therapeutics has 13 employees.
Who are Antios Therapeutics competitors?
Competitors of Antios Therapeutics include Vitality Biopharma, Opiant Pharmaceuticals and IntelGenx.
Where is Antios Therapeutics headquarters?
Antios Therapeutics headquarters is located at P.O. Box 12260, Atlanta.
Where are Antios Therapeutics offices?
Antios Therapeutics has an office in Atlanta.
How many offices does Antios Therapeutics have?
Antios Therapeutics has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies